Cholecystokinin Octapeptide free acid (desulfated) is a full-length CCK derivative lacking the sulfation modification, enabling studies of altered receptor affinity. Its structure allows detailed mapping of functional residues within the octapeptide. Researchers use it to analyze folding behavior and ligand versatility. The molecule supports advanced exploration of CCK signaling determinants.
CAT No: C21040
Synonyms/Alias:103974-46-5;Cholecystokinin Octapeptide free acid (desulfated);(3S)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid;Cholecystokinin (26-33) (free acid);HY-P3651;DA-62294;FC108595;CS-0616841;H-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-OH; H-DYMGWMDF-OH;Cholecystokinin Octapeptide free acid (desulfated),Sincalide (free acid) (desulfated);
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More